{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:59:54Z","timestamp":1793408394415,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003921","name":"Department of Health, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Influenza vaccines are utilised to combat seasonal and pandemic influenza. The key to influenza vaccination currently is the availability of candidate vaccine viruses (CVVs). Ideally, CVVs reflect the antigenic characteristics of the circulating virus, which may vary depending upon the isolation method. For traditional inactivated egg-based vaccines, CVVs are isolated in embryonated chicken eggs, while for cell-culture production, CVV\u2019s are isolated in either embryonated eggs or qualified cell lines. We compared isolation rates, growth characteristics, genetic stability and antigenicity of cell and egg CVV\u2019s derived from the same influenza-positive human clinical respiratory samples collected from 2008\u20132020. Influenza virus isolation rates in MDCK33016PF cells were twice that of eggs and mutations in the HA protein were common in egg CVVs but rare in cell CVVs. These results indicate that fully cell-based influenza vaccines will improve the choice, match and potentially the effectiveness, of seasonal influenza vaccines compared to egg-based vaccines.<\/jats:p>","DOI":"10.1038\/s41541-021-00415-3","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T11:12:09Z","timestamp":1639048329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Enhanced isolation of influenza viruses in qualified cells improves the probability of well-matched vaccines"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3651-2839","authenticated-orcid":false,"given":"Heidi","family":"Peck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5186-8342","authenticated-orcid":false,"given":"Karen L.","family":"Laurie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Rockman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilda","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Soppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cleve","family":"Rynehart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Baas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Trusheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian G.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,9]]},"reference":[{"key":"415_CR1","doi-asserted-by":"publisher","first-page":"020421","DOI":"10.7189\/jogh.09.020421","volume":"9","author":"J Paget","year":"2019","unstructured":"Paget, J. et al. Global mortality associated with seasonal influenza epidemics: new burden estimates and predictors from the GLaMOR Project. J. Glob. Health 9, 020421 (2019).","journal-title":"J. Glob. Health"},{"key":"415_CR2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","volume":"391","author":"AD Iuliano","year":"2018","unstructured":"Iuliano, A. D. et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 391, 1285\u20131300 (2018).","journal-title":"Lancet"},{"key":"415_CR3","unstructured":"WHO. Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza (WHO, 2011)."},{"key":"415_CR4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/infdis\/141.3.362","volume":"141","author":"M Baez","year":"1980","unstructured":"Baez, M., Palese, P. & Kilbourne, E. D. Gene composition of high-yielding influenza vaccine strains obtained by recombination. J. Infect. Dis. 141, 362\u2013365 (1980).","journal-title":"J. Infect. Dis."},{"key":"415_CR5","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3390\/microorganisms8111745","volume":"8","author":"S Rockman","year":"2020","unstructured":"Rockman, S., Laurie, K. L., Parkes, S., Wheatley, A. & Barr, I. G. New technologies for influenza vaccines. Microorganisms 8, 1745 (2020).","journal-title":"Microorganisms"},{"key":"415_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-1-4899-1382-1_19","volume":"397","author":"OW Merten","year":"1996","unstructured":"Merten, O. W., Hannoun, C., Manuguerra, J. C., Ventre, F. & Petres, S. Production of influenza virus in cell cultures for vaccine preparation. Adv. Exp. Med. Biol. 397, 141\u2013151 (1996).","journal-title":"Adv. Exp. Med. Biol."},{"key":"415_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0166-0934(93)90036-Q","volume":"42","author":"SK Schepetiuk","year":"1993","unstructured":"Schepetiuk, S. K. & Kok, T. The use of MDCK, MEK and LLCMK2 cell lines with enzyme immunoassay for the isolation of influenza and parainfluenza viruses from clinical specimens. J. Virol. Methods 42, 241\u2013250 (1993).","journal-title":"J. Virol. Methods"},{"key":"415_CR8","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1128\/am.16.4.588-594.1968","volume":"16","author":"CR Gaush","year":"1968","unstructured":"Gaush, C. R. & S, T. F. Replication and plaque assay of influenza virus in an established line of canine kidney cells. Appl. Microbiol. 16, 588\u2013594 (1968).","journal-title":"Appl. Microbiol."},{"key":"415_CR9","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1128\/JCM.00398-08","volume":"46","author":"DY Oh","year":"2008","unstructured":"Oh, D. Y., Barr, I. G., Mosse, J. A. & Laurie, K. L. MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells. J. Clin. Microbiol. 46, 2189\u20132194 (2008).","journal-title":"J. Clin. Microbiol."},{"key":"415_CR10","doi-asserted-by":"publisher","first-page":"E8276","DOI":"10.1073\/pnas.1806133115","volume":"115","author":"JM Lee","year":"2018","unstructured":"Lee, J. M. et al. Deep mutational scanning of hemagglutinin helps predict evolutionary fates of human H3N2 influenza variants. Proc. Natl Acad. Sci. USA 115, E8276\u2013E8285 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"415_CR11","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/s41564-019-0433-6","volume":"4","author":"K Takada","year":"2019","unstructured":"Takada, K. et al. A humanized MDCK cell line for the efficient isolation and propagation of human influenza viruses. Nat. Microbiol. 4, 1268\u20131273 (2019).","journal-title":"Nat. Microbiol."},{"key":"415_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/infdis\/172.1.250","volume":"172","author":"EA Govorkova","year":"1995","unstructured":"Govorkova, E. A., Kaverin, N. V., Gubareva, L. V., Meignier, B. & Webster, R. G. Replication of influenza A viruses in a green monkey kidney continuous cell line (Vero). J. Infect. Dis. 172, 250\u2013253 (1995).","journal-title":"J. Infect. Dis."},{"key":"415_CR13","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.1128\/jvi.70.8.5519-5524.1996","volume":"70","author":"EA Govorkova","year":"1996","unstructured":"Govorkova, E. A., Murti, G., Meignier, B., de Taisne, C. & Webster, R. G. African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses. J. Virol. 70, 5519\u20135524 (1996).","journal-title":"J. Virol."},{"key":"415_CR14","doi-asserted-by":"publisher","first-page":"9517","DOI":"10.1128\/JVI.75.19.9517-9525.2001","volume":"75","author":"SH Seo","year":"2001","unstructured":"Seo, S. H., Goloubeva, O., Webby, R. & Webster, R. G. Chacterization of a porcine lung epithelial cell line suitable for influenza virus studies. J. Virol. 75, 9517\u20139525 (2001).","journal-title":"J. Virol."},{"key":"415_CR15","doi-asserted-by":"publisher","first-page":"e01091","DOI":"10.1128\/JVI.01091-20","volume":"94","author":"V Meliopoulos","year":"2020","unstructured":"Meliopoulos, V. et al. Primary swine respiratory epithelial cell lines for the efficient isolation and propagation of influenza A viruses. J. Virol. 94, e01091\u201320. (2020).","journal-title":"J. Virol."},{"key":"415_CR16","first-page":"419","volume":"64","author":"SW Brown","year":"2010","unstructured":"Brown, S. W. & Mehtali, M. The avian EB66 cell line, application to vaccines, and therapeutic protein production. PDA J. Pharm. Sci. Tech. 64, 419\u2013425 (2010).","journal-title":"PDA J. Pharm. Sci. Tech."},{"key":"415_CR17","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1016\/j.vaccine.2010.05.031","volume":"28","author":"MP Girard","year":"2010","unstructured":"Girard, M. P., Tam, J. S., Assossou, O. M. & Kieny, M. P. The 2009 A (H1N1) influenza virus pandemic: a review. Vaccine 28, 4895\u20134902 (2010).","journal-title":"Vaccine"},{"key":"415_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3390\/vaccines8020211","volume":"8","author":"S Rockman","year":"2020","unstructured":"Rockman, S., Laurie, K. L. & Barr, I. Pandemic influenza vaccines:what did we learn from the 2009 pandemic and are we better prepared now? Vaccines 8, 211 (2020).","journal-title":"Vaccines"},{"key":"415_CR19","doi-asserted-by":"publisher","first-page":"12578","DOI":"10.1073\/pnas.1712377114","volume":"114","author":"SJ Zost","year":"2017","unstructured":"Zost, S. J. et al. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc. Natl Acad. Sci. USA 114, 12578\u201383. (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"415_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.7774\/cevr.2020.9.1.56","volume":"9","author":"YW Park","year":"2020","unstructured":"Park, Y. W. et al. Comparison of antigenic mutation during egg and cell passage cultivation of H3N2 influenza virus. Clin. Exp. Vaccin. Res. 9, 56\u201363 (2020).","journal-title":"Clin. Exp. Vaccin. Res."},{"key":"415_CR21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1006\/viro.1993.1461","volume":"196","author":"WJ Meyer","year":"1993","unstructured":"Meyer, W. J. et al. Influence of host cell-mediated variation on the international surveillance of influenza A (H3N2) viruses. Virology 196, 130\u2013137 (1993).","journal-title":"Virology"},{"key":"415_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-018-0079-z","volume":"3","author":"IG Barr","year":"2018","unstructured":"Barr, I. G. et al. Cell culture-derived influenza vaccines in the severe 2017\u20132018 epidemic season: a step towards improved influenza vaccine effectiveness. npj Vaccines 3, 44 (2018).","journal-title":"npj Vaccines"},{"key":"415_CR23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/jmv.20178","volume":"74","author":"T Saito","year":"2004","unstructured":"Saito, T. et al. Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation. J. Med. Virol. 74, 336\u2013343 (2004).","journal-title":"J. Med. Virol."},{"key":"415_CR24","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1099\/jgv.0.000457","volume":"97","author":"L Parker","year":"2016","unstructured":"Parker, L. et al. Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses. J. Gen. Virol. 97, 1333\u201344. (2016).","journal-title":"J. Gen. Virol."},{"key":"415_CR25","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1016\/j.vaccine.2014.02.014","volume":"32","author":"IG Barr","year":"2014","unstructured":"Barr, I. G. et al. WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013. Vaccine 32, 4713\u20134725 (2014).","journal-title":"Vaccine"},{"key":"415_CR26","doi-asserted-by":"publisher","first-page":"e92153","DOI":"10.1371\/journal.pone.0092153","volume":"9","author":"DM Skowronski","year":"2014","unstructured":"Skowronski, D. M. et al. Low 2012\u201313 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS ONE 9, e92153 (2014).","journal-title":"PLoS ONE"},{"key":"415_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.15585\/mmwr.mm6706a1","volume":"67","author":"AP Budd","year":"2018","unstructured":"Budd, A. P. et al. Update: influenza activity - United States, October 1, 2017\u2013February 3, 2018. MMWR Morb. Mortal. Wkly. Rep. 67, 169\u2013179 (2018).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"415_CR28","unstructured":"WHO. WHO recommendations on the composition of influenza virus vaccines. https:\/\/www.who.int\/influenza\/vaccines\/virus\/recommendations\/en\/ (2020)."},{"key":"415_CR29","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.chom.2019.04.013","volume":"25","author":"NC Wu","year":"2019","unstructured":"Wu, N. C. et al. Preventing an antigenically disruptive mutation in egg-based H3N2 seasonal influenza vaccines by mutational incompatibility. Cell Host Microbe 25, 836\u201344. (2019).","journal-title":"Cell Host Microbe"},{"key":"415_CR30","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.biologicals.2010.04.003","volume":"38","author":"D Onions","year":"2010","unstructured":"Onions, D., Egan, W., Jarrett, R., N, R. & Gregersen, J. P. Validation of the safety of MDCK cells as a substrate for the production of a cell-derived influenza vaccine. Biologicals 38, 544\u2013551 (2010).","journal-title":"Biologicals"},{"key":"415_CR31","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.vaccine.2011.11.063","volume":"30","author":"B Roth","year":"2012","unstructured":"Roth, B., Mohr, H., Enders, M., Garten, W. & Gregersen, J.-P. Isolation of influenza viruses in MDCK 33016PF cells and clearance of contaminating respiratory viruses. Vaccine 30, 517\u2013522 (2012).","journal-title":"Vaccine"},{"key":"415_CR32","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1016\/j.vaccine.2008.03.076","volume":"26","author":"JP Gregersen","year":"2008","unstructured":"Gregersen, J. P. A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines. Vaccine 26, 3297\u20133304 (2008).","journal-title":"Vaccine"},{"key":"415_CR33","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1016\/j.vaccine.2008.03.075","volume":"26","author":"JP Gregersen","year":"2008","unstructured":"Gregersen, J. P. A quantitative risk assessment of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine. Vaccine 26, 3332\u201340. (2008).","journal-title":"Vaccine"},{"key":"415_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39276-1","volume":"9","author":"PA Jorquera","year":"2019","unstructured":"Jorquera, P. A. et al. Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011\u20132018. Sci. Rep. 9, 2676 (2019).","journal-title":"Sci. Rep."},{"key":"415_CR35","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1089\/vim.2013.0111","volume":"27","author":"IG Ovsyannikova","year":"2014","unstructured":"Ovsyannikova, I. G., White, S. J., Albrecht, R. A., G-S, A. & Poland, G. A. Turkey versus guinea pig red blood cells: hemagglutination differences alter hemagglutination inhibition responses against influenza A\/H1N1. Viral. Immunol. 27, 174\u2013178 (2014).","journal-title":"Viral. Immunol."},{"key":"415_CR36","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/0042-6822(84)90158-2","volume":"138","author":"RS Daniels","year":"1984","unstructured":"Daniels, R. S. et al. Antigenic analyses of influenza virus haemagglutinins with different receptor-binding specificities. Virol. 138, 174\u2013177 (1984).","journal-title":"Virol"},{"key":"415_CR37","doi-asserted-by":"publisher","first-page":"6691","DOI":"10.1016\/j.vaccine.2006.05.062","volume":"24","author":"B Lu","year":"2006","unstructured":"Lu, B., Zhou, H., Chan, W., Kemble, G. & Jin, H. Single amino acid substitutions in the hemagglutinin of influenza A\/Singapore\/21\/04 (H3N2) increase virus growth in embryonated chicken eggs. Vaccine 24, 6691\u20136693 (2006).","journal-title":"Vaccine"},{"key":"415_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16183-y","volume":"11","author":"S Gouma","year":"2020","unstructured":"Gouma, S., W, M. & Hensley, S. E. Antigenic assessment of the H3N2 component of the 2019-2020 Northern Hemisphere influenza vaccine. Nat. Commun. 11, 2445 (2020).","journal-title":"Nat. Commun."},{"key":"415_CR39","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1093\/cid\/ciz411","volume":"69","author":"EA Belongia","year":"2019","unstructured":"Belongia, E. A. & McLean, H. Q. Influenza vaccine effectiveness: defining the H3N2 problem. Clin. Infect. Dis. 69, 1817\u201323. (2019).","journal-title":"Clin. Infect. Dis."},{"key":"415_CR40","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jinf.2019.11.005","volume":"80","author":"F Wen","year":"2020","unstructured":"Wen, F., Huang, S. & Guo, J. Egg adaptive mutation patterns of H3N2 human influenza A viruses. J. Infect. 80, 232\u201354. (2020).","journal-title":"J. Infect."},{"key":"415_CR41","doi-asserted-by":"publisher","first-page":"eaav2554","DOI":"10.1126\/sciadv.aav2554","volume":"5","author":"L Byrd-Leotis","year":"2019","unstructured":"Byrd-Leotis, L. et al. Influenza binds phosphorylated glycans from human lung. Sci. Adv. 5, eaav2554 (2019).","journal-title":"Sci. Adv."},{"key":"415_CR42","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.1073\/pnas.0308001101","volume":"101","author":"MN Matrosovich","year":"2004","unstructured":"Matrosovich, M. N., Matrosovich, T. Y., Gray, T., Roberts, N. A. & Klenk, H. D. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl Acad. Sci. USA 101, 4620\u20134624 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"415_CR43","doi-asserted-by":"publisher","first-page":"8060","DOI":"10.1128\/JVI.00384-06","volume":"80","author":"CI Thompson","year":"2006","unstructured":"Thompson, C. I., Barclay, W. S., Zambon, M. C. & Pickles, R. J. Infection of human airway epithelium by human and avian strains of influenza A virus. J. Virol. 80, 8060\u20138068 (2006).","journal-title":"J. Virol."},{"key":"415_CR44","doi-asserted-by":"publisher","first-page":"e1003223","DOI":"10.1371\/journal.ppat.1003223","volume":"9","author":"T Walther","year":"2013","unstructured":"Walther, T. et al. Glycomic analysis of human respiratory tract tissues and correlation with influenza virus infection. PLoS Pathog. 9, e1003223 (2013).","journal-title":"PLoS Pathog."},{"key":"415_CR45","doi-asserted-by":"publisher","first-page":"8418","DOI":"10.1128\/JVI.77.15.8418-8425.2003","volume":"77","author":"M Matrosovich","year":"2003","unstructured":"Matrosovich, M., Matrosovich, T., Carr, J., Roberts, N. A. & Klenk, H.-D. Overexpression of the a-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J. Virol. 77, 8418\u201325. (2003).","journal-title":"J. Virol."},{"key":"415_CR46","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4172\/1747-0862.1000026","volume":"3","author":"SV Kuchipudi","year":"2009","unstructured":"Kuchipudi, S. V. et al. Differences in influenza virus receptors in chickens and ducks: implications for interspecies transmission. J. Mol. Genet. Med. 3, 143\u2013151 (2009).","journal-title":"J. Mol. Genet. Med."},{"key":"415_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-7-5","volume":"7","author":"SP Pillai","year":"2010","unstructured":"Pillai, S. P. & L, C. Species and age related differences in the type and distribution of influenza virus receptors in different tissues of chickens, ducks and turkeys. Virol. J. 7, 5 (2010).","journal-title":"Virol. J."},{"key":"415_CR48","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10719-008-9193-x","volume":"26","author":"N Sriwilaijaroen","year":"2009","unstructured":"Sriwilaijaroen, N. et al. Analysis of N-glycans in embryonated chicken egg chorioallantoic and amniotic cells responsible for binding and adaptation of human and avian influenza viruses. Glycoconj. J. 26, 433\u2013443 (2009).","journal-title":"Glycoconj. J."},{"key":"415_CR49","doi-asserted-by":"publisher","first-page":"21474","DOI":"10.1073\/pnas.1218841110","volume":"109","author":"YP Lin","year":"2012","unstructured":"Lin, Y. P. et al. Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin. Proc. Natl Acad. Sci. USA 109, 21474\u201321479 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"415_CR50","doi-asserted-by":"publisher","first-page":"6769","DOI":"10.1128\/JVI.00458-10","volume":"84","author":"YP Lin","year":"2010","unstructured":"Lin, Y. P. et al. Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic siteL a role in virus attachment? J. Virol. 84, 6769\u20136781 (2010).","journal-title":"J. Virol."},{"key":"415_CR51","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/irv.12447","volume":"11","author":"Y Lin","year":"2017","unstructured":"Lin, Y. et al. The characteristics and antigenic properties of recently emerged subclade 3C.3a and 3C.2a human influenza A(H3N2) viruses passaged in MDCK cells. Influenza Other Respir. Viruses 11, 263\u201374. (2017).","journal-title":"Influenza Other Respir. Viruses"},{"key":"415_CR52","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1073\/pnas.90.9.4171","volume":"90","author":"JW Drake","year":"1993","unstructured":"Drake, J. W. Rates of spontaneous mutation among RNA viruses. Proc. Natl Acad. Sci. USA 90, 4171\u20134175 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"415_CR53","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1126\/science.1178258","volume":"326","author":"SE Hensley","year":"2009","unstructured":"Hensley, S. E. et al. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 326, 734\u2013736 (2009).","journal-title":"Science"},{"key":"415_CR54","doi-asserted-by":"publisher","first-page":"6015","DOI":"10.1128\/JVI.74.13.6015-6020.2000","volume":"74","author":"LJ Mitnaul","year":"2000","unstructured":"Mitnaul, L. J. et al. Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J. Virol. 74, 6015\u20136020 (2000).","journal-title":"J. Virol."},{"key":"415_CR55","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2807\/1560-7917.ES.2017.22.43.17-00707","volume":"22","author":"SG Sullivan","year":"2017","unstructured":"Sullivan, S. G. et al. Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017. Eur. Surveill. 22, 17\u201300707. (2017).","journal-title":"Eur. Surveill."},{"key":"415_CR56","unstructured":"WHO. WHO collaborating centres for influenza and their terms of reference. https:\/\/www.who.int\/influenza\/gisrs_laboratory\/collaborating_centres\/list\/en\/ (2021)."},{"key":"415_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jcv.2015.04.019","volume":"68","author":"Y-M Deng","year":"2015","unstructured":"Deng, Y.-M. et al. A simplified Sanger sequencing method for full genome sequencing of multiple subtypes of human influenza A viruses. J. Clin. Virol. 68, 43\u201348 (2015).","journal-title":"J. Clin. Virol."},{"key":"415_CR58","unstructured":"BII Flusurver. http:\/\/flusurver.bii.a-star.edu.sg (2020)."},{"key":"415_CR59","doi-asserted-by":"publisher","first-page":"e01673","DOI":"10.1128\/JVI.01673-18","volume":"93","author":"W Sun","year":"2019","unstructured":"Sun, W. et al. Antibody responses toward the major antigenic sites of influenza B virus hemagglutinin in mice, ferrets, and humans. J. Virol. 93, e01673\u201318. (2019).","journal-title":"J. Virol."},{"key":"415_CR60","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1128\/JVI.02477-07","volume":"82","author":"Q Wang","year":"2008","unstructured":"Wang, Q., Cheng, F., Lu, M., Tian, X. & Ma, J. Crystal structure of unligated influenza B virus hemagglutinin. J. Virol. 82, 3011\u20133020 (2008).","journal-title":"J. Virol."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-021-00415-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-021-00415-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-021-00415-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T23:24:00Z","timestamp":1670023440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-021-00415-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,9]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["415"],"URL":"https:\/\/doi.org\/10.1038\/s41541-021-00415-3","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,9]]},"assertion":[{"value":"27 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.L.L., C.B. and S.R. are employees of Seqirus Ltd that manufactures influenza seasonal and pandemic vaccines. I.G.B. has shares in an influenza vaccine manufacturing company.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}